Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness

No abstract is available for this paper.

• Publication year

  2018

• Venue

  HYPERTENSION

• Publication date

  2018-09-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.118.11065PMID 29987104PMCID PMC6202147
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting autophagy in obesity: from pathophysiology to management

  2018cited by this paper
• Spironolactone is superior to hydrochlorothiazide for blood pressure control and arterial stiffness improvement

  2018cited by this paper
• Enhanced endothelium epithelial sodium channel signaling prompts left ventricular diastolic dysfunction in obese female mice.

  2018cited by this paper
• Arterial stiffness and peripheral vascular resistance in offspring of hypertensive parents: influence of sex and other confounders

  2018cited by this paper
• Aldosterone, SGK1, and ion channels in the kidney

  2018cited by this paper
• Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity

  2018cited by this paper
• Mechanoactivation of the angiotensin II type 1 receptor induces β‐arrestin‐biased signaling through Gαi coupling

  2018cited by this paper
• Pharmacologic inhibition of the enzymatic effects of tissue transglutaminase reduces cardiac fibrosis and attenuates cardiomyocyte hypertrophy following pressure overload.

  2018cited by this paper
• Vascular smooth muscle contraction in hypertension

  2018cited by this paper
• Smooth Muscle Cell–Mineralocorticoid Receptor as a Mediator of Cardiovascular Stiffness With Aging

  2018cited by this paper
• Cellular mechanisms underlying obesity-induced arterial stiffness.

  2018cited by this paper
• Recent Advances in Angiotensin Research

  2017cited by this paper
• Amiloride Improves Endothelial Function and Reduces Vascular Stiffness in Female Mice Fed a Western Diet

  2017cited by this paper
• Reversal of Arterial Stiffness and Maladaptative Arterial Remodeling After Kidney Transplantation

  2017cited by this paper
• Abdominal Obesity Is Associated With an Increased Risk of All-Cause Mortality in Patients With HFpEF.

  2017cited by this paper
• The endothelial αENaC contributes to vascular endothelial function in vivo

  2017cited by this paper
• Tissue Transglutaminase Modulates Vascular Stiffness and Function Through Crosslinking‐Dependent and Crosslinking‐Independent Functions

  2017cited by this paper
• AT1 receptor signaling pathways in the cardiovascular system

  2017cited by this paper
• A meta-analytical comparison of atenolol with angiotensin-converting enzyme inhibitors on arterial stiffness, peripheral blood pressure and heart rate in hypertensive patients

  2017cited by this paper
• Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells

  2017cited by this paper
• Long-term effects of a renin inhibitor versus a thiazide diuretic on arterial stiffness and left ventricular diastolic function in elderly hypertensive patients.

  2017cited by this paper
• Vascular Smooth Muscle Cells and Arterial Stiffening: Relevance in Development, Aging, and Disease.

  2017cited by this paper
• Lysyl oxidase overexpression accelerates cardiac remodeling and aggravates angiotensin II–induced hypertrophy

  2017cited by this paper
• Prevalence, Correlates, and Prognosis of Healthy Vascular Aging in a Western Community-Dwelling Cohort: The Framingham Heart Study

  2017cited by this paper
• Are genetic polymorphisms in the renin–angiotensin–aldosterone system associated with essential hypertension? Evidence from genome-wide association studies

  2017cited by this paper
• Vascular dysfunction and fibrosis in stroke-prone spontaneously hypertensive rats: The aldosterone-mineralocorticoid receptor-Nox1 axis

  2017cited by this paper
• The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study

  2017cited by this paper
• Association of renin–angiotensin–aldosterone system gene polymorphisms with left ventricular hypertrophy in patients with heart failure with preserved ejection fraction: A case–control study

  2017cited by this paper
• Loss of vascular smooth muscle cell autophagy exacerbates angiotensin II‐associated aortic remodeling

  2017cited by this paper
• The Role of MicroRNAs in Arterial Stiffness and Arterial Calcification. An Update and Review of the Literature

  2017cited by this paper
• Vascular Mineralocorticoid Receptors: Linking Risk Factors, Hypertension, and Heart Disease.

  2016cited by this paper
• Drp 1-Dependent Mitochondrial Autophagy Plays a Protective Role Against Pressure-Overload-Induced Mitochondrial Dysfunction and Heart Failure

  2016cited by this paper
• Time course and factors predicting arterial stiffness reversal in patients with aldosterone-producing adenoma after adrenalectomy: prospective study of 102 patients

  2016cited by this paper
• Endothelial Mineralocorticoid Receptor Mediates Diet-Induced Aortic Stiffness in Females.

  2016cited by this paper
• miR-155 functions downstream of angiotensin II receptor subtype 1 and calcineurin to regulate cardiac hypertrophy.

  2016cited by this paper
• Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection Fraction

  2016cited by this paper
• Age-Associated Changes in the Vascular Renin-Angiotensin System in Mice

  2016cited by this paper
• Immune activation caused by vascular oxidation promotes fibrosis and hypertension.

  2016cited by this paper
• TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis.

  2016cited by this paper
• Aldosterone-Induced Vascular Remodeling and Endothelial Dysfunction Require Functional Angiotensin Type 1a Receptors

  2016cited by this paper
• Vascular mineralocorticoid receptor regulates microRNA-155 to promote vasoconstriction and rising blood pressure with aging.

  2016cited by this paper
• Compromised blood–brain barrier permeability: novel mechanism by which circulating angiotensin II signals to sympathoexcitatory centres during hypertension

  2016cited by this paper
• Mouse Sirt3 promotes autophagy in AngII-induced myocardial hypertrophy through the deacetylation of FoxO1

  2016cited by this paper
• Small artery mechanobiology: Roles of cellular and non‐cellular elements

  2016cited by this paper
• Drp1-Dependent Mitochondrial Autophagy Plays a Protective Role Against Pressure Overload–Induced Mitochondrial Dysfunction and Heart Failure

  2016cited by this paper
• Could Modification of Titin Contribute to an Answer for Heart Failure With Preserved Ejection Fraction?

  2016cited by this paper
• Epigenetics and obesity cardiomyopathy: From pathophysiology to prevention and management.

  2016cited by this paper
• Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

  2016cited by this paper
• Therapeutic Modulation of Aortic Stiffness

  2016cited by this paper
• MicroRNA-34b/c inhibits aldosterone-induced vascular smooth muscle cell calcification via a SATB2/Runx2 pathway

  2016cited by this paper
• Autophagy activation attenuates angiotensin II-induced cardiac fibrosis.

  2016cited by this paper
• Mechanical activation of angiotensin II type 1 receptors causes actin remodelling and myogenic responsiveness in skeletal muscle arterioles

  2016cited by this paper
• Function, Role, and Clinical Application of MicroRNAs in Vascular Aging

  2016cited by this paper
• Renin Overexpression Leads to Increased Titin‐Based Stiffness Contributing to Diastolic Dysfunction in Hypertensive mRen2 Rats

  2016cited by this paper
• RBM20 is an essential factor for thyroid hormone-regulated titin isoform transition.

  2015cited by this paper
• Toll‐like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II‐induced hypertension

  2015cited by this paper
• Toll-Like Receptor 4 Knockout Protects Against Isoproterenol-Induced Cardiac Fibrosis

  2015cited by this paper
• Effect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients With Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Meta‐Analysis and Systematic Review

  2015cited by this paper
• Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology

  2015cited by this paper
• RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients.

  2015cited by this paper
• The impact of angiotensin receptor blockers on arterial stiffness: a meta-analysis

  2015cited by this paper
• Endothelial Mineralocorticoid Receptor Deletion Prevents Diet-Induced Cardiac Diastolic Dysfunction in Females

  2015cited by this paper
• Augmented Vascular Smooth Muscle Cell Stiffness and Adhesion When Hypertension Is Superimposed on Aging

  2015cited by this paper
• Angiotensin Ⅱ Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4.

  2015cited by this paper
• Mineralocorticoid receptor blockade prevents vascular remodelling in a rodent model of type 2 diabetes mellitus.

  2015cited by this paper
• Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet–Induced Arterial Stiffening in Female Mice

  2015cited by this paper
• Drug Therapy of Apparent Treatment-Resistant Hypertension: Focus on Mineralocorticoid Receptor Antagonists

  2015cited by this paper
• Histone Methyltransferase SET1 Mediates Angiotensin II–Induced Endothelin-1 Transcription and Cardiac Hypertrophy in Mice

  2015cited by this paper
• Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association.

  2015cited by this paper
• Effect of Lysyl Oxidase Inhibition on Angiotensin II-Induced Arterial Hypertension, Remodeling, and Stiffness

  2015cited by this paper
• Heart failure with preserved ejection fraction in the elderly: scope of the problem.

  2015cited by this paper
• Vasoactive agonists exert dynamic and coordinated effects on vascular smooth muscle cell elasticity, cytoskeletal remodelling and adhesion

  2014cited by this paper
• Renin-sensitive microRNAs correlate with atherosclerosis plaque progression

  2014cited by this paper
• Aldosterone and vascular mineralocorticoid receptors: regulators of ion channels beyond the kidney.

  2014cited by this paper
• Mineralocorticoid receptor signaling: crosstalk with membrane receptors and other modulators.

  2014cited by this paper
• Experimentally Increasing Titin Compliance in a Novel Mouse Model Attenuates the Frank-Starling Mechanism But Has a Beneficial Effect on Diastole

  2014cited by this paper
• Diverse functions of matrix metalloproteinases during fibrosis

  2014cited by this paper
• Adaptor Protein p66Shc Mediates Hypertension-Associated, Cyclic Stretch–Dependent, Endothelial Damage

  2014cited by this paper
• Cardiac-specific suppression of NF-κB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system.

  2014cited by this paper
• Endothelial Cell Mineralocorticoid Receptors Regulate Deoxycorticosterone/Salt-Mediated Cardiac Remodeling and Vascular Reactivity But Not Blood Pressure

  2014cited by this paper
• The role of ENaC in vascular endothelium

  2014cited by this paper
• Smooth Muscle Cell Mineralocorticoid Receptors Are Mandatory for Aldosterone–Salt to Induce Vascular Stiffness

  2014cited by this paper
• Inflammation and Mechanical Stretch Promote Aortic Stiffening in Hypertension Through Activation of p38 Mitogen-Activated Protein Kinase

  2013cited by this paper
• Arterial Stiffening Precedes Systolic Hypertension in Diet-Induced Obesity

  2013cited by this paper
• Fluid Shear Stress induces the Clustering of Heparan Sulfate via Mobility of Glypican‐1 in Lipid Rafts

  2013cited by this paper
• Skinfold Thickness as a Predictor of Arterial Stiffness: Obesity and Fatness Linked to Higher Stiffness Measurements in Hypertensive Patients

  2013cited by this paper
• Angiotensin II Regulates microRNA-132/-212 in Hypertensive Rats and Humans

  2013cited by this paper
• Increased tissue transglutaminase activity contributes to central vascular stiffness in eNOS knockout mice.

  2013cited by this paper
• Mineralocorticoid Receptor–Mediated Vascular Insulin Resistance

  2013cited by this paper
• The Role of Tissue Renin-Angiotensin-Aldosterone System in the Development of Endothelial Dysfunction and Arterial Stiffness

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• Markers of Inflammation, Endothelial Activation, and Arterial Stiffness in Hypertensive Heart Disease and the Effects of Treatment: Results From the SILVHIA Study

  2013cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  2012cited by this paper
• Contribution of Impaired Mitochondrial Autophagy to Cardiac Aging: Mechanisms and Therapeutic Opportunities

  2012cited by this paper
• Temporal analysis of vascular smooth muscle cell elasticity and adhesion reveals oscillation waveforms that differ with aging

  2012cited by this paper
• Coordination of fibronectin adhesion with contraction and relaxation in microvascular smooth muscle.

  2012cited by this paper
• Spironolactone Prevents Chlorthalidone-Induced Sympathetic Activation and Insulin Resistance in Hypertensive Patients

  2012cited by this paper
• Vascular Actions of Aldosterone

  2012cited by this paper
• Corticosteroids, heart failure, and hypertension: a role for immune cells?

  2012cited by this paper

• Apical-Predominant Myocardial Fibrosis in Hypertensive Heart Disease Revealed by CMR Feature Tracking and T1 Mapping

  2026cites this paper
• Echocardiographic evaluation and clinical implications of cardiac remodeling in obesity.

  2026cites this paper
• Recent advances and emerging perspectives in vascular and cardiovascular research: A 2025 update.

  2026cites this paper
• Advances in the Pharmacological Treatment of Heart Failure With Preserved Ejection Fraction

  2026cites this paper
• GLP-1 Receptor Agonists in Heart Failure

  2025cites this paper
• Statins to reduce renal sinus fat among breast cancer patients undergoing anthracycline-based chemotherapy: A substudy of PREVENT-WF-98213

  2025cites this paper
• Clinical and Biochemical Outcomes of Super‐Selective Adrenal Artery Embolization in Primary Aldosteronism: A Systematic Review and Meta‐Analysis

  2025cites this paper
• The angiotensin II type 2 receptor attenuates aging-associated arterial stiffness in female mice.

  2025cites this paper
• Vascular (dys)function in the failing heart

  2025cites this paper
• A study on the evaluation of left atrial function in lupus nephritis patients using left atrial automated functional imaging technology

  2025cites this paper
• The novel effects of Aspalathus linearis (Rooibos) against angiotensin-II-induced hypertrophy in H9C2 cardiomyoblasts

  2025cites this paper
• Vascular actions of Ang 1-7 and Ang 1-8 through EDRFs and EDHFs in non-diabetes and diabetes mellitus.

  2025cites this paper
• PET imaging of cardiac sympathetic nervous system dysfunction using meta-[18F]fluorobenzylguanidine.

  2025cites this paper
• Doxorubicin-Induced Cardiac Remodeling: Mechanisms and Mitigation Strategies

  2025cites this paper
• The renin‐angiotensin‐aldosterone system and salt sensitivity of blood pressure offer new insights in obesity phenotypes

  2025cites this paper
• A perspective on intermittent fasting and cardiovascular risk in the era of obesity pharmacotherapy

  2025cites this paper
• Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential

  2025cites this paper
• Pharmacologic Management of Heart Failure with Preserved Ejection Fraction (HFpEF) in Older Adults

  2025cites this paper
• Elucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging.

  2025cites this paper
• Special Issue “The Angiotensin in Human Health and Diseases”

  2025cites this paper
• Frailty and cardiovascular disease: a bidirectional relationship with clinical implications

  2025cites this paper
• Impact of renal function on left atrial function and left atrioventricular interaction in hypertension with preserved ejection fraction using cardiac magnetic resonance.

  2025cites this paper
• Revisiting renin-angiotensin-aldosterone system in aging: translational insights from bench to bedside and back

  2025cites this paper
• Evaluation of myocardial classic and alternative pathways of the renin-angiotensin system in cholestasis-induced cardiac injury: A time-course experimental study in rats

  2025cites this paper
• Renin-Angiotensin System Inhibitors in Patients With Nonproteinuric Chronic Kidney Disease and Kidney Outcomes: Findings From the CRIC Study

  2025cites this paper
• Effect of furosemide on comprehensive renin‐angiotensin‐aldosterone system activity of Thoroughbred horses

  2024cites this paper
• Metabolic Syndrome Nonalcoholic Steatohepatitis Male Mouse With Adeno‐Associated Viral Renin as a Novel Model for Heart Failure With Preserved Ejection Fraction

  2024cites this paper
• Hypertension induced by peri-pubertal protein restriction depends on renin-angiotensin system dysfunction in adult male rats.

  2024cites this paper
• Postoperative Adhesions: Current Research on Mechanisms, Therapeutics and Preventative Measures

  2024cites this paper
• Echocardiographic Evaluation of Left Ventricular Hypertrophy

  2024cites this paper
• Association of central arterial stiffness with atrial myopathy: the Atherosclerosis Risk in Communities (ARIC) study

  2024cites this paper
• Cardiac Effects of Renin-Angiotensin System Inhibitors in Nonproteinuric CKD

  2024cites this paper
• Vitamin D as a predictor of clinical response among patients with cardiac resynchronization therapy (CRT)

  2024cites this paper
• Multi-Target In-Silico modeling strategies to discover novel angiotensin converting enzyme and neprilysin dual inhibitors

  2024cites this paper
• Impact of RAAS Receptors and Membrane-Bound Transporter System in the Left Ventricle during the Long-Term Control of Hypertension

  2024cites this paper
• Sudden cardiac death due to ventricular arrhythmia in diabetes mellitus: A bench to bedside review.

  2024cites this paper
• Beyond blood pressure, fluid and electrolyte homeostasis – Role of the renin angiotensin aldosterone system in the interplay between metabolic diseases and breast cancer

  2024cites this paper
• Decoding the role of aldosterone in glycation-induced diabetic complications.

  2024cites this paper
• Association of left ventricular diastolic dysfunction with inflammatory activity, renal dysfunction, and liver-related mortality in patients with cirrhosis and ascites

  2024cites this paper
• Effect of Mineralocorticoid receptor antagonism (MRA) on aldosterone-interleukin 6 axis in heart failure; second opinion. A case-control study

  2024cites this paper
• Mitochondrial fission inhibition protects against hypertension induced by angiotensin II

  2024cites this paper
• Cirrhotic cardiomyopathy: a subject that's always topical

  2024cites this paper
• Early impact of albuminuria on cardiac function in patients with chronic kidney disease: a prospective study

  2024cites this paper
• Efficacy and safety assessment of mineralocorticoid receptor antagonists in patients with chronic kidney disease.

  2023cites this paper
• An emerging view on vascular fibrosis molecular mediators and relevant disorders: from bench to bed

  2023cites this paper
• Exercise-Induced Blood Pressure Dynamics: Insights from the General Population and the Athletic Cohort

  2023cites this paper
• Higher plasma aldosterone concentrations in patients with aortic diseases and hypertension: a retrospective observational study

  2023cites this paper
• Left ventricle hypertrophy and re-modeling in children with essential hypertension: does the race matter?

  2023cites this paper
• Sleep-disordered breathing patterns and prognosis in pulmonary arterial hypertension: A cluster analysis of nocturnal cardiorespiratory signals.

  2023cites this paper
• Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failure.

  2023cites this paper
• Exploring the Complex Relationship between Diabetes and Cardiovascular Complications: Understanding Diabetic Cardiomyopathy and Promising Therapies

  2023cites this paper
• Hallmarks of cardiovascular ageing

  2023cites this paper
• Extracellular Vesicle MicroRNAs in Heart Failure: Pathophysiological Mediators and Therapeutic Targets

  2023cites this paper
• Impact of diabetes on remodelling, microvascular function and exercise capacity in aortic stenosis

  2023cites this paper
• The Relationship between Renin–Angiotensin–Aldosterone System (RAAS) Activity, Osteoporosis and Estrogen Deficiency in Type 2 Diabetes

  2023cites this paper
• The Association Between Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Exposure and Key Cirrhosis-Related Outcomes

  2023cites this paper
• Rapid kidney function decline and increased risk of heart failure in patients with type 2 diabetes: findings from the ACCORD cohort

  2023cites this paper
• Understanding the Pathogenesis of Cardiac Complications in Patients with Propionic Acidemia and Exploring Therapeutic Alternatives for Those Who Are Not Eligible or Are Waiting for Liver Transplantation

  2023cites this paper
• Cardiomyocyte-specific deletion of TLR4 attenuates angiotensin II-induced hypertension and cardiac remodeling

  2023cites this paper
• Effect of active vitamin-D on left ventricular mass index: results of a randomised controlled trial in type 2 diabetes and chronic kidney disease.

  2023cites this paper
• When blood pressure refuses to budge: exploring the complexity of resistant hypertension

  2023cites this paper
• Finerenone: A New Era for Mineralocorticoid Receptor Antagonism and Cardiorenal Protection.

  2022cites this paper
• Prevalence of obesity and its association with cardiometabolic risk factors, heart failure phenotype and mortality among patients hospitalized for heart failure in Egypt

  2022cites this paper
• Associations among body composition parameters and quality of life in peritoneal dialysis patients

  2022cites this paper
• Hypertension in obese children is associated with vitamin D deficiency and serotonin dysregulation

  2022cites this paper
• Investigation of the Antiremodeling Effects of Losartan, Mirabegron and Their Combination on the Development of Doxorubicin-Induced Chronic Cardiotoxicity in a Rat Model

  2022cites this paper
• The Pathogenesis of Cardiac Fibrosis: A Review of Recent Progress

  2022cites this paper
• The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets

  2022cites this paper
• Inhibition of sphingomyelinase attenuates diet - Induced increases in aortic stiffness.

  2022cites this paper
• Prognostic implications of traditional and non‐traditional cardiovascular risk factor profiles in patients with non‐valvular atrial fibrillation

  2022cites this paper
• Effect of Heart Rate on 1‐Year Outcome for Patients With Acute Ischemic Stroke

  2022cites this paper
• Identification Of the Effect Of Hyperbaric Oxygen Therapy (Hbot) On Blood Pressure Lowering Effects In Hypertension Patient

  2022influential citation
• Angiotensin II receptor blockers (ARBs) and manufacturing contamination: A retrospective National Register Study into suspected associated adverse drug reactions

  2022cites this paper
• RBM20, a Therapeutic Target to Alleviate Myocardial Stiffness via Titin Isoforms Switching in HFpEF

  2022cites this paper
• The Atrium in Atrial Fibrillation – A Clinical Review on How to Manage Atrial Fibrotic Substrates

  2022cites this paper
• TRPM7 deficiency exacerbates cardiovascular and renal damage induced by aldosterone-salt

  2022cites this paper
• Association between antihypertensive medication and the risk of urinary tract infection (UTI) of outpatients: a retrospective cohort study

  2022cites this paper
• Dahl salt-resistant rats are protected against angiotensin II-induced hypertension.

  2022cites this paper
• Role of Cigarette Smoking on Serum Angiotensin-Converting Enzyme and Its Association With Inflammation and Lipid Peroxidation

  2022cites this paper
• Mineralocorticoid Receptor Activation in Vascular Insulin Resistance and Dysfunction

  2022influential citation
• Hypertension and human immunodeficiency virus: A paradigm for epithelial sodium channels?

  2022cites this paper
• Novel Therapies for the Treatment of Cardiac Fibrosis Following Myocardial Infarction

  2022cites this paper
• HIV-Related Myocardial Fibrosis: Inflammatory Hypothesis and Crucial Role of Immune Cells Dysregulation

  2022cites this paper
• Current Management of Heart Failure with Preserved Ejection Fraction.

  2022cites this paper
• Reviewing the Modern Therapeutical Options and the Outcomes of Sacubitril/Valsartan in Heart Failure

  2022cites this paper
• Advances in pathogenesis and treatment of essential hypertension

  2022cites this paper
• Transient gene therapy using cell cycle factors reverses renin–angiotensin–aldosterone system activation in heart failure rat model

  2022cites this paper
• Right Ventricle in Arterial Hypertension: Did We Forget Something?

  2022cites this paper
• The Role of MicroRNAs in Dilated Cardiomyopathy: New Insights for an Old Entity

  2022cites this paper
• The Renin–Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes

  2022cites this paper
• Circulating Biomarkers in Hypertrophic Cardiomyopathy

  2022cites this paper
• Recent Developments in the Evaluation and Management of Cardiorenal Syndrome: A Comprehensive Review.

  2022cites this paper
• Editorial: The effects of circulating non-sex hormones in cardiovascular disease

  2022cites this paper
• Assessing clinical and biomarker characteristics to optimize the benefits of sacubitril/valsartan in heart failure

  2022cites this paper
• Evaluation of Regional Myocardial Work Indices in Pediatric Essential and Renal or Renovascular Hypertension.

  2022cites this paper
• Long-chain noncoding RNA-GAS5/hsa-miR-138-5p attenuates high glucose-induced cardiomyocyte damage by targeting CYP11B2

  2021cites this paper
• Inhibition of neprilysin with sacubitril without RAS blockage aggravates renal disease in Dahl SS rats

  2021cites this paper
• Management of hypertension in patients with COVID-19: Implication of angiotensin-converting enzyme 2

  2021influential citation
• Diastolic Dysfunction in Systemic Sclerosis: Risk Factors and Impact on Mortality

  2021cites this paper
• Heightened Cardiovascular Risk in Hypertension Associated With Renin‐Independent Aldosteronism Versus Renin‐Dependent Aldosteronism: A Collaborative Study

  2021cites this paper